CompletedPhase 4ketamine
Effect of S-ketamine in Cesarean Section Combined Anesthesia
Sponsored by The Second Affiliated Hospital of Chongqing Medical University
NCT ID
NCT05414006
Target Enrollment
120 participants
Start Date
2022-06-14
Est. Completion
2022-09-05
About This Study
To compare the anti-hyperalgesia effect between S-ketamine with placebo for Maternal receiving elective Cesarean Section under Combined spinal and epidural analgesia. Based on this study the investigators intend to verify the role and potential mechanism of S-ketamine combined anesthesia in alleviating hyperalgesia after cesarean section, prove that it can reduce hyperalgesia and postoperative pain. explore the role of S-ketamine in alleviating postoperative hyperalgesia in different PCA ways and explore the safety of S-ketamine in the perilactation
Conditions Studied
Interventions
- •S-ketamine
Eligibility
Sex:FEMALE
Age:20 Years - 45 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * ASA status I-III * Age 20 to 45 * 37-42 weeks gestation * undergo elective cesarean section with subarachnoid anesthesia * participate in this study and sign informed consent Exclusion Criteria: * Patients with contraindications for cesarean section * Patients with contraindications of combined spinal and epidural anesthesia * Patients with severe systemic disease * Alcoholism and long-term use of anti-inflammatory and analgesic drugs * Patients who were unable to cooperate or refused to participate in the trial * Patients with contraindications to esketamine and hydromorphone
Study Locations (1)
Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University
Chongqing, Chongqing Municipality, China